Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+ 
DoorDash Q2 Revenue Jumps 36% as Orders and DashPass Growth Drive Results 
OpenAI Restricts Astra AI Over Cyberattack Risks 
Heineken H1 Operating Profit Meets Forecast as Beer Volumes Beat Expectations 
UOB Q2 Net Profit Rises 10% as Wealth Management Growth Boosts Earnings 
SoftBank Q1 Profit Beats Forecast as Intel Rally and OpenAI Investments Boost Returns 
Nvidia Seen Beating Q2 Targets as Vera Rubin Cycle Begins 
SK Hynix, Samsung Lead Asian Chip Stock Selloff After Sandisk, Western Digital Outlook 
Meta Ordered to Pay $567M Over Child Safety Violations in New Mexico 
Western Digital Q4 Earnings Beat Estimates as FY2027 Outlook Tops Expectations 
Cloudflare Stock Jumps 15% as Earnings Beat Estimates, 2026 Outlook Raised 
Alphabet Stock Slides as Google AI Pioneer Jeff Dean Exits to Launch Discovery Loop 
Qantas Shares Climb as Long-Haul Pilot Deal Eases Strike Concerns 
DBS Raises 2025 Outlook After Record Q2 Profit Driven by Wealth Management 
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback 
DeepSeek to Raise AI API Prices as Demand for New Models Surges 
Berkshire Hathaway Cash Falls as Abel Boosts Stock Buybacks 
 Investors of the April 10, 2018 Lead Plaintiff Deadline in the Pending Securities Class Action Linked to Capital Preservation Disclosures - EconoTimes)
SAN FRANCISCO, Feb. 27, 2018 -- Hagens Berman Sobol Shapiro LLP reminds investors in LJM Preservation and Growth Fund (NASDAQ:LJMIX) of the April 10, 2018 Lead Plaintiff deadline in the pending securities class action. If you purchased or otherwise acquired securities of LJMIX between February 28, 2015 and February 7, 2018 and suffered losses contact Hagens Berman Sobol Shapiro LLP. For more information, visit:
https://www.hbsslaw.com/cases/LJMIX
or contact Reed Kathrein, who is leading the firm’s investigation, by calling 510-725-3000 or emailing
The complaint charges defendants made false and/or misleading statements or did not disclose that LJMIX was not focused on capital preservation but instead exposed investors to high risks of catastrophic losses. When on February 5, 2012 the S&P fell about 4.6 percent, the price of LJMIX fell approximately 80 percent during two trading days to close at $1.94 on February 7, 2018.
“We’re focused on the apparent difference between defendants’ statements concerning the LJMIX investment goals and the true strategies which inflicted enormous losses on LJMIX investors,” said Hagens Berman partner Reed Kathrein.
Whistleblowers: Persons with non-public information regarding LJMIX should consider their options to help in the investigation or take advantage of the SEC whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 510-725-3000 or email [email protected].
About Hagens Berman
Hagens Berman is a national investor-rights law firm headquartered in Seattle, Washington with 70+ attorneys in 11 offices across the country. The firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the firm and its successes can be found at www.hbsslaw.com. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.
Contact:
Reed Kathrein, 510-725-3000
